Abstract:Background Systemic sclerosis (SSc) is an autoimmune disease characterized by vasculopathy, inflammation, and extensive fibrosis of the skin and organs. Exosomes (EXOs) are cell-derived vesicles 30-150 nm in size that contain various mRNAs, microRNAs and proteins. Objectives Here, we aimed to investigate the roles of EXOs in SSc pathogenesis, especially in angiogenesis. Methods EXOs were respectively isolated from plasma, cultured peripheral blood mononuclear cells (PBMCs) and neutrophil supernatants, and were identified by transmission electron microscopy. The expression of S100A8/A9 was measured by real-time PCR and ELISA. Proliferation, migration and scratch assays in human dermal microvascular endothelial cells (HDMECs) were used to study the influence of neutrophil EXOs and neutrophil EXOs S100A8/A9. We also performed a genome-wide transcriptome analysis on PBMCs from 19 SSc patients and 18 matched normal controls (NC) using Illumina BeadChip arrays. The ingenuity pathway analysis (IPA) tool and Database for Annotation, Visualization and Integrated Discovery (DAVID) were used for bioinformatics analysis. Results Plasma EXOs and neutrophil EXOs from SSc patients suppressed the proliferation and migration of HDMECs. Using a microarray analysis we found 28% genes upregulated in PBMCs could exist in EXOs, especially the S100 protein family, including S100A8/A9. High levels of S100A8/A9 were consistently verified in SSc plasma, PBMCs, plasma EXOs, PBMC EXOs and neutrophil EXOs. Particularly, S100A8/A9 expression in neutrophil EXOs was distinctly higher than that in PBMC EXOs in SSc patients. Furthermore, we found that neutrophil EXOs S100A8/A9 inhibit the proliferation and migration of HDMECs, and that might through Toll-like receptor 4 (TLR4) pathway. Conclusion S100A8/A9 is one of components of neutrophil EXOs that regulates vascular endothelial cell angiogenesis in SSc patients, most likely by activating the TLR4 signalling pathway. Acknowledgement This study was funded by grants from the National Key Research and Development Program of China (2016YFC0903900), National Natural Science Foundation of China (81671622), Hunan Provincial Natural Science Foundation (2018JJ3823), Clinical Research Fund of Xiangya Hospital Central South University (2014L10) and Independent Innovation Projects of Central South University (2018zzst290). Disclosure of Interests None declared

Neutrophil-secreted S100A8/A9 participates in fatty liver injury and fibrosis by promoting myofibroblast migration

S100A9 Promotes Human Lung Fibroblast Cells Activation Through Receptor for Advanced Glycation End-Product-mediated Extracellular-Regulated Kinase 1/2, Mitogen-Activated Protein-Kinase and Nuclear Factor-Κb-dependent Pathways

S100A4 promotes liver fibrosis via activation of hepatic stellate cells.

Effect of S100A9 on human lung fibroblast proliferation and activity

Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility

Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury

S100A9 regulates M1 macrophage polarization and exacerbates steatotic liver ischemia-reperfusion injury

[Mechanism of Hepatic Stellate Cell Migration During Liver Fibrosis].

S100A9 Promotes Inflammatory Response in Diabetic Nonalcoholic Fatty Liver Disease.

Targeting S100A9 Prevents β-Adrenergic Activation–Induced Cardiac Injury

The S100 calcium binding protein A11 promotes liver fibrogenesis by targeting TGF-β signaling

Migration Of Hepatic Stellate Cells In Fibrotic Microenvironment Of Diseased Liver Model

Neutrophils undergo switch of apoptosis to NETosis during murine fatty liver injury via S1P receptor 2 signaling

Cytosolic S100A8/A9 promotes Ca supply at LFA-1 adhesion clusters during neutrophil recruitment

S100A4 Promotes Hepatocellular Carcinogenesis by Intensifying Fibrosis-Associated Cancer Cell Stemness

CD11b+CD43hiLy6Clo splenocyte‐derived macrophages exacerbate liver fibrosis via spleen‐liver axis

S100A8-Mediated NLRP3 Inflammasome-Dependent Pyroptosis in Macrophages Facilitates Liver Fibrosis Progression

Therapeutic Effects of Recombinant Human S100A6 and Soluble Receptor for Advanced Glycation End Products(srage) on CCl4-induced Liver Fibrosis in Mice.

Single‐Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell–Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice

AB0211 NEUTROPHIL-DERIVED EXOSOME S100A8/A9 INHIBITS ANGIOGENESIS IN SYSTEMIC SCLEROSIS

S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis.